The Lancet. Respiratory medicine. 2023 Mar 13. doi: 10.1016/S2213-2600(22)00535-5. pii: S2213-2600(22)00535-5 |
Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement. |
Di Nardo M1, MacLaren G2, Schellongowski P3, Azoulay E4, DeZern AE5, Gutierrez C6, Antonelli M7, Antonini MV8, Beutel G9, Combes A10, Diaz R11, Fawzy Hassan I12, Fowles JA13, Jeong IS14, Kochanek M15, Liebregts T16, Lueck C17, Moody K18, Moore JA19, Munshi L20, Paden M21, Pène F22, Puxty K23, Schmidt M24, Staudacher D25, Staudinger T26, Stemmler J27, Stephens RS28, Vande Vusse L29, Wohlfarth P30, Lorusso R31, Amodeo A32, Mahadeo KM33, Brodie D34 |
Abstract Combined advances in haematopoietic cell transplantation (HCT) and intensive care management have improved the survival of patients with haematological malignancies admitted to the intensive care unit. In cases of refractory respiratory failure or refractory cardiac failure, these advances have led to a renewed interest in advanced life support therapies, such as extracorporeal membrane oxygenation (ECMO), previously considered inappropriate for these patients due to their poor prognosis. Given the scarcity of evidence-based guidelines on the use of ECMO in patients receiving HCT and the need to provide equitable and sustainable access to ECMO, the European Society of Intensive Care Medicine, the Extracorporeal Life Support Organization, and the International ECMO Network aimed to develop an expert consensus statement on the use of ECMO in adult patients receiving HCT. A steering committee with expertise in ECMO and HCT searched the literature for relevant articles on ECMO, HCT, and immune effector cell therapy, and developed opinion statements through discussions following a Quaker-based consensus approach. An international panel of experts was convened to vote on these expert opinion statements following the Research and Development/University of California, Los Angeles Appropriateness Method. The Appraisal of Guidelines for Research and Evaluation statement was followed to prepare this Position Paper. 36 statements were drafted by the steering committee, 33 of which reached strong agreement after the first voting round. The remaining three statements were discussed by all members of the steering committee and expert panel, and rephrased before an additional round of voting. At the conclusion of the process, 33 statements received strong agreement and three weak agreement. This Position Paper could help to guide intensivists and haematologists during the difficult decision-making process regarding ECMO candidacy in adult patients receiving HCT. The statements could also serve as a basis for future research focused on ECMO selection criteria and bedside management. |
Copyright © 2023 Elsevier Ltd. All rights reserved. |
Publikations ID: 36924784 Quelle: öffnen |